John Radford
Impact in
- Pathology and Forensic Medicine top 0.02%
- Lymphoma Diagnosis and Treatment
- Oncology top 0.1%
- CAR-T cell therapy research
- Viral-associated cancers and disorders
Papers in
-
- Lymphoma Diagnosis and Treatment 229
- Oncology 133
- Viral-associated cancers and disorders 42
- CAR-T cell therapy research 37
- HER2/EGFR in Cancer Research 14
- Co-authors
- Peter Johnson (53 shared papers)D. Crowther (27 shared papers)A. Z. S. Rohatiner (20 shared papers)Ruth Pettengell (23 shared papers)David Cunningham (23 shared papers)David C. Linch (21 shared papers)Barry W. Hancock (16 shared papers)Pier Luigi Zinzani (34 shared papers)
- Journals
- Blood (84 papers)Journal of Clinical Oncology (59 papers)Annals of Oncology (23 papers)British Journal of Cancer (21 papers)Hematological Oncology (20 papers)
- Partner nations
- United KingdomUnited StatesItaly
In The Last Decade
John Radford
373 papers receiving 16.1k citations
John Radford's Hit Papers
Peers
Comparison fields: 5 of 170
- Pathology and Forensic Medicine 8.4k
- Oncology 6.8k
- Genetics 2.7k
- Neurology 2.1k
- Reproductive Medicine 892
Countries citing papers authored by John Radford
This map shows the geographic impact of John Radford's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Radford with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Radford more than expected).
Fields of papers citing papers by John Radford
This network shows the impact of papers produced by John Radford. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Radford. The network helps show where John Radford may publish in the future.
Co-authors
The 25 scholars most cited alongside John Radford, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 385 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: a multicenter phase II study. Hit paper breakdown → | 1998 | 753 |
| 2 | Phase II Study of the Efficacy and Safety of Pembrolizumab for Relapsed/Refractory Classic Hodgkin Lymphoma Hit paper breakdown → | 2017 | 721 |
| 3 | Results of a Trial of PET-Directed Therapy for Early-Stage Hodgkin’s Lymphoma Hit paper breakdown → | 2015 | 439 |
| 4 | 2000 | 392 | |
| 5 | Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles Hit paper breakdown → | 2013 | 379 |
| 6 | 2005 | 355 | |
| 7 | 1992 | 348 | |
| 8 | 2007 | 347 | |
| 9 | 2008 | 343 | |
| 10 | 2003 | 340 | |
| 11 | 2001 | 317 | |
| 12 | 2000 | 301 | |
| 13 | 2001 | 293 | |
| 14 | Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma (LOTIS-2): a multicentre, open-label, single-arm, phase 2 trial Hit paper breakdown → | 2021 | 284 |
| 15 | 1992 | 281 | |
| 16 | 2010 | 254 | |
| 17 | 2019 | 233 | |
| 18 | 2008 | 213 | |
| 19 | 1999 | 210 | |
| 20 | 2007 | 200 |
About John Radford
John Radford is a scholar working on Pathology and Forensic Medicine, Oncology, Pulmonary and Respiratory Medicine, Genetics and Radiology, Nuclear Medicine and Imaging, having authored 385 papers that have together received 16.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (229 papers), Chronic Lymphocytic Leukemia Research (77 papers), Lung Cancer Treatments and Mutations (60 papers), Viral-associated cancers and disorders (42 papers), CAR-T cell therapy research (37 papers), CNS Lymphoma Diagnosis and Treatment (35 papers), Monoclonal and Polyclonal Antibodies Research (27 papers) and HER2/EGFR in Cancer Research (14 papers). The work is most often cited by research in Pathology and Forensic Medicine (8.4k citations), Oncology (6.8k citations), Genetics (2.7k citations), Neurology (2.1k citations) and Reproductive Medicine (892 citations). John Radford has collaborated with scholars based in United Kingdom, United States and Italy. Frequent co-authors include Peter Johnson, D. Crowther, A. Z. S. Rohatiner, Ruth Pettengell, David Cunningham, David C. Linch, Barry W. Hancock, Pier Luigi Zinzani, Jean‐Yves Blay and Martin Harris. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.